Market Closed

SLDB
Solid Biosciences
$ 6.84
-2.29%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Solid Biosciences News

Latest Solid Biosciences Stock News & SLDB Headlines

Solid Biosciences to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
10 days ago | globenewswire.com
Solid Biosciences Reports Third Quarter 2026 Financial Results and Provides Business Updates
10 days ago | globenewswire.com
Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich's Ataxia
20 days ago | globenewswire.com
Solid Biosciences (SLDB) Expected to Announce Quarterly Earnings on Monday
20 days ago | defenseworld.net
Solid Biosciences to Present Research Across Gene Therapy Development, Delivery and Manufacturing at ESGCT 2026
a month ago | globenewswire.com
Solid Biosciences: A Funded Challenge To Duchenne Gene Therapy's Limitations
2 months ago | seekingalpha.com
Solid Biosciences Inc. (SLDB) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
2 months ago | seekingalpha.com
Solid Biosciences to Participate at Upcoming Investor Conferences
2 months ago | globenewswire.com
Solid Biosciences: The Bull Case Is No Longer Just Duchenne
4 months ago | seekingalpha.com
Solid Biosciences Inc. (SLDB) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
5 months ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

SLDB
Solid Biosciences
$ 6.84
-2.29%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago